New Agreement for Radiation Therapy Cancer Treatment

January 3, 2011 — Calypso Medical Technologies Inc., a developer of real-time localization technology used for the precise tracking of tumors, and Elekta, a manufacturer of medical devices and software for treating cancer, announced a master development agreement to jointly develop products integrating the Calypso System with Elekta’s radiotherapy treatment technologies.

Integrating the Calypso System into Elekta’s radiotherapy technologies may facilitate the development of innovative treatment modalities for treating prostate cancer, as well as more problematic radiation therapy targets, such as the pancreas and lung, according to Calypso. Efforts will include creating connectivity between the linear accelerator and the Calypso system for patient positioning during radiation delivery.

The Calypso system is complementary to Elekta’s technology for delivering intensity-modulated radiotherapy (IMRT), including Elekta Synergy and Precise linear accelerators.

For more information: www.elekta.com, www.calypsomedical.com